What Happened
Lincoln Pharmacy in Tacoma, Washington, agreed in February 2023 to pay the United States $80,000 to settle claims that it failed to comply with administrative requirements of the Controlled Substances Act. According to the settlement, a June 2021 DEA inspection found the pharmacy did not maintain records for substances such as oxycodone and hydrocodone between March 2020 and June 2021, kept inadequate inventories, did not record deliveries, failed to secure some controlled substances, and did not keep its private key secure. The pharmacy did not admit liability.
“Lincoln Pharmacy will pay the United States $80,000 to resolve the claims.”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.